Style | Citing Format |
---|---|
MLA | Assar S, et al.. "Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment." Journal of Immunology Research, vol. 2021, no. , 2021, pp. -. |
APA | Assar S, Khazaei H, Naseri M, Elsenduny F, Momtaz S, Farzaei MH, Echeverria J (2021). Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment. Journal of Immunology Research, 2021(), -. |
Chicago | Assar S, Khazaei H, Naseri M, Elsenduny F, Momtaz S, Farzaei MH, Echeverria J. "Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment." Journal of Immunology Research 2021, no. (2021): -. |
Harvard | Assar S et al. (2021) 'Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment', Journal of Immunology Research, 2021(), pp. -. |
Vancouver | Assar S, Khazaei H, Naseri M, Elsenduny F, Momtaz S, Farzaei MH, et al.. Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment. Journal of Immunology Research. 2021;2021():-. |
BibTex | @article{ author = {Assar S and Khazaei H and Naseri M and Elsenduny F and Momtaz S and Farzaei MH and Echeverria J}, title = {Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment}, journal = {Journal of Immunology Research}, volume = {2021}, number = {}, pages = {-}, year = {2021} } |
RIS | TY - JOUR AU - Assar S AU - Khazaei H AU - Naseri M AU - Elsenduny F AU - Momtaz S AU - Farzaei MH AU - Echeverria J TI - Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment JO - Journal of Immunology Research VL - 2021 IS - SP - EP - PY - 2021 ER - |